CRISPR Therapeutics AG (CRSP) has 12 identified peers for comparison in the Healthcare sector. Peers include AVRO, BEAM, CRBU, CWBR, EDIT, FATE and others.
CRSP has a market capitalization of $5.46B, compared to an average peer market cap of $22.22B. CRSP is notably smaller than its average peer.